Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.

Analytics

Biotechnology

Ambagon Therapeutics

The Eindhoven office specializes in biochemical research and development, focusing on innovative scientific advancements.

Eindhoven

Ambagon Therapeutics' headquarters in San Francisco, CA, United States

Laura Demmers

Loes Stevers

Donna Olivia Debets

Taggra Jackson

Rens de Vries

Willem van den Hout

Eline Sijbesma

Tanja Meyer

Guido Oerlemans

Carolyn Bertozzi

Alan Ashworth

Steve Davidsen

Geraldine Harriman

Ali Tavassoli

Peter Dudek

Michelle Arkin

Janwillem Naesens

Margarita Chavez

Luc Brunsveld

The Scientific Research Team at Ambagon Therapeutics focuses on discovering and developing small molecule cancer drugs that target and stabilize interactions between oncogenic proteins and the 14-3-3 class of adaptor proteins. This team conducts structural biology research, biochemistry assays, proteomics analysis, and bioinformatics to identify and optimize potential drug candidates. Collaboration among scientists, research associates, and directors ensures the integration of cutting-edge research techniques to advance therapeutic discoveries.

Scientific Research Team

The Directors Team at Ambagon Therapeutics oversees strategic planning, decision-making, and management related to the development of small molecule cancer drugs. They ensure alignment with the company's mission, drive key projects forward, and provide leadership across various departmental functions to advance the company’s therapeutic discoveries.

Directors Team

The Scientific Advisory Team at Ambagon Therapeutics provides expert guidance on the development and optimization of small molecule cancer drugs. Leveraging their extensive knowledge in computational chemistry and oncology, the team advises on experimental design, molecular interactions, and the strategic direction of the company's research initiatives to stabilize oncogenic protein interactions with 14-3-3 adaptor proteins.

Scientific Advisory Team

The Leadership Team at Ambagon Therapeutics is responsible for setting the strategic direction of the company and overseeing the development of innovative small molecule cancer therapies. Comprising experts in technology, science, and chemistry, the team collaborates to drive research initiatives, foster partnerships, and ensure alignment with the company's mission to target oncogenic proteins effectively. Their collective expertise guides decision-making and resource allocation to advance drug discovery and development efforts.

Ambagon Therapeutics

Org chart

Board & advisors

Teams

Scientific Research Team

Directors Team

Scientific Advisory Team

Leadership Team

Offices

Ambagon Therapeutics

Org chart

Board & advisors

Teams

Scientific Research Team

Directors Team

Scientific Advisory Team

Leadership Team

Offices

Related companies